Relationship between efficacy and preferential targeting of soluble Aβ aggregates
Alzheimer’s Association (2025), (Vol 11, Issue 4). DOI: 10.1002/trc2.70184
Protocol for in vitro phagocytosis assay for primary mouse microglia and human embryonic stem cell-derived microglia
STAR Protocols (2025), (Vol 6, Issue 4). DOI: 10.1016/j.xpro.2025.104219.
The Alzheimer’s therapeutic Lecanemab attenuates Aβ pathology by inducing an amyloid-clearing program in microglia
Nat Neurosci (2025). DOI: 10.1038/s41593-025-02125-8
Targeting of amyloid peptide fibers, a biomarker of Alzheimer’s disease, by designing specifically functionalized Iron Oxide Nanoparticles
HAL. (2025), 8 (43), pp.20822-20834. DOI:10.1021/acsanm.5c03459
Role of P-glycoprotein in attenuation of retinal amyloid-β peptide (1–40) clearance across the rat inner blood-retinal barrier induced by lipopolysaccharide
Science Direct (2025), 262. DOI: 10.1016/j.exer.2025.110759.
Peptidomimetics Based on C-Terminus of Blm10 Stimulate Human 20S Proteasome Activity and Promote Degradation of Proteins
Biomolecules (2022), 12, 777. DOI: 10.3390/biom12060777
Detection of extracellular amyloid beta aggregates by an Aducanumab-based synNotch receptor: an in vitro proof-of-concept study
J Transl Med 23, 1255 (2025). DOI: 10.1186/s12967-025-07324-2
Inhibitory Effect of Insulin-Degrading Enzyme-Selective Inhibitor, Ii1, on the Elimination of Amyloid-β(1-40) from Rat Brain
Biol. Pharm. Bull. 48, 1700–1707 (2025). DOI: 10.1248/bpb.b25-00424
Cell-type-specific dysregulation of mitochondrial calcium signaling in Alzheimer’s disease
Cell Commun Signal 23, 472 (2025). DOI: 10.1186/s12964-025-02460-0
Cognitive function correlates with gastric alpha-synuclein seeding activity in early Parkinson’s disease
NPJ Parkinsons Dis. 11, 311 (2025). DOI: 10.1038/s41531-025-01152-3